Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Celgene Corporation
ClinicalTrials.gov Identifier:
NCT00064974
First received: July 16, 2003
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
No publications provided by Celgene Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):